Alicia M Alcamo1,2, Lauren J Alessi1,2, S Noona Vehovic1,2, Neha Bansal3, Geoffrey J Bond4, Joseph A Carcillo1,2, Michael Green2, Marian G Michaels2, Rajesh K Aneja1,2. 1. Department of Critical Care Medicine, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA. 2. Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA. 3. Division of Pediatric Cardiology, Department of Pediatrics, Children's Hospital of Montefiore, Bronx, NY. 4. Departments of Transplant Surgery and General and Thoracic Pediatric Surgery, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA.
Abstract
OBJECTIVES: To describe characteristics of liver transplant patients with severe sepsis in the PICU. DESIGN: Retrospective descriptive analysis. SETTING: Tertiary children's hospital PICU. PATIENTS: Liver transplant recipients admitted January 2010 to July 2016 for pediatric severe sepsis. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Between January 2010 and July 2016, 173 liver transplants were performed, and 36 of these patients (21%) were admitted with severe sepsis (54 episodes total). Median age at admission was 2 years (1-6.5 yr), 47.2% were male. Bacterial infections were the most common (77.8%), followed by culture negative (12.9%) and viral infections (7.4%). Fungal infections accounted for only 1.9%. Median time from transplant for viral and culture negative infections was 18 days (8.25-39.75 d) and 25 days (9-41 d), whereas 54.5 days (17-131.25 d) for bacterial infections. Bloodstream and intra-abdominal were the most common bacterial sites (45% and 22.5%, respectively). Multidrug-resistant organisms accounted for 47.6% of bacterial sepsis. Vancomycin-resistant Enterococcus and extended-spectrum beta-lactamase producers were the most frequently identified multidrug-resistant organisms. Patients with multidrug-resistant organism sepsis demonstrated higher admission Pediatric Logistic Organ Dysfunction scores (p = 0.043) and were noted to have an odds ratio of 3.8 and 3.6 for mechanical ventilation and multiple organ dysfunction syndrome, respectively (p = 0.047 and p = 0.044). Overall mortality was 5.5% (n = 2 patients), with both deaths occurring in multidrug-resistant organism episodes. CONCLUSIONS: We report that multidrug-resistant organisms are increasingly being identified as causative pathogens for sepsis in pediatric liver transplant recipients and are associated with significantly higher odds for mechanical ventilation and higher organ failure. The emergence of multidrug-resistant organism infections in pediatric liver transplant patients has implications for patient outcomes, antibiotic stewardship, and infection prevention strategies.
OBJECTIVES: To describe characteristics of liver transplant patients with severe sepsis in the PICU. DESIGN: Retrospective descriptive analysis. SETTING: Tertiary children's hospital PICU. PATIENTS: Liver transplant recipients admitted January 2010 to July 2016 for pediatric severe sepsis. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Between January 2010 and July 2016, 173 liver transplants were performed, and 36 of these patients (21%) were admitted with severe sepsis (54 episodes total). Median age at admission was 2 years (1-6.5 yr), 47.2% were male. Bacterial infections were the most common (77.8%), followed by culture negative (12.9%) and viral infections (7.4%). Fungal infections accounted for only 1.9%. Median time from transplant for viral and culture negative infections was 18 days (8.25-39.75 d) and 25 days (9-41 d), whereas 54.5 days (17-131.25 d) for bacterial infections. Bloodstream and intra-abdominal were the most common bacterial sites (45% and 22.5%, respectively). Multidrug-resistant organisms accounted for 47.6% of bacterial sepsis. Vancomycin-resistant Enterococcus and extended-spectrum beta-lactamase producers were the most frequently identified multidrug-resistant organisms. Patients with multidrug-resistant organism sepsis demonstrated higher admission Pediatric Logistic Organ Dysfunction scores (p = 0.043) and were noted to have an odds ratio of 3.8 and 3.6 for mechanical ventilation and multiple organ dysfunction syndrome, respectively (p = 0.047 and p = 0.044). Overall mortality was 5.5% (n = 2 patients), with both deaths occurring in multidrug-resistant organism episodes. CONCLUSIONS: We report that multidrug-resistant organisms are increasingly being identified as causative pathogens for sepsis in pediatric liver transplant recipients and are associated with significantly higher odds for mechanical ventilation and higher organ failure. The emergence of multidrug-resistant organism infections in pediatric liver transplant patients has implications for patient outcomes, antibiotic stewardship, and infection prevention strategies.
Authors: Deirdre A Kelly; John C Bucuvalas; Estella M Alonso; Saul J Karpen; Upton Allen; Michael Green; Douglas Farmer; Eyal Shemesh; Ruth A McDonald Journal: Liver Transpl Date: 2013-08 Impact factor: 5.799
Authors: Alan L Davis; Joseph A Carcillo; Rajesh K Aneja; Andreas J Deymann; John C Lin; Trung C Nguyen; Regina S Okhuysen-Cawley; Monica S Relvas; Ranna A Rozenfeld; Peter W Skippen; Bonnie J Stojadinovic; Eric A Williams; Tim S Yeh; Fran Balamuth; Joe Brierley; Allan R de Caen; Ira M Cheifetz; Karen Choong; Edward Conway; Timothy Cornell; Allan Doctor; Marc-Andre Dugas; Jonathan D Feldman; Julie C Fitzgerald; Heidi R Flori; James D Fortenberry; Ana Lia Graciano; Bruce M Greenwald; Mark W Hall; Yong Yun Han; Lynn J Hernan; Jose E Irazuzta; Elizabeth Iselin; Elise W van der Jagt; Howard E Jeffries; Saraswati Kache; Chhavi Katyal; Niranjan Kissoon; Alexander A Kon; Martha C Kutko; Graeme MacLaren; Timothy Maul; Renuka Mehta; Fola Odetola; Kristine Parbuoni; Raina Paul; Mark J Peters; Suchitra Ranjit; Karin E Reuter-Rice; Eduardo J Schnitzler; Halden F Scott; Adalberto Torres; Jacki Weingarten-Arams; Scott L Weiss; Jerry J Zimmerman; Aaron L Zuckerberg Journal: Crit Care Med Date: 2017-06 Impact factor: 7.598
Authors: L Ashkenazi-Hoffnung; Y Mozer-Glassberg; E Bilavsky; R Yassin; R Shamir; J Amir Journal: Transpl Infect Dis Date: 2016-05-17 Impact factor: 2.228
Authors: François Proulx; Jean Sébastien Joyal; M Michele Mariscalco; Stéphane Leteurtre; Francis Leclerc; Jacques Lacroix Journal: Pediatr Crit Care Med Date: 2009-01 Impact factor: 3.624
Authors: Patrick D Mauldin; Cassandra D Salgado; Ida Solhøj Hansen; Darshana T Durup; John A Bosso Journal: Antimicrob Agents Chemother Date: 2009-10-19 Impact factor: 5.191
Authors: Jonathan A Fridell; Ashok Jain; Jorge Reyes; Rebecca Biederman; Michael Green; Rakesh Sindhi; George V Mazariegos Journal: Transplantation Date: 2002-12-27 Impact factor: 4.939
Authors: Alicia M Alcamo; Lauren J Alessi; S Noona Vehovic; Neha Bansal; Geoffrey J Bond; Joseph A Carcillo; Michael Green; Marian G Michaels; Rajesh K Aneja Journal: Pediatr Crit Care Med Date: 2019-11 Impact factor: 3.624
Authors: Emad Hamdy Gad; Ahmed Nabil Sallam; Hosam Soliman; Tarek Ibrahim; Tahany Abdel Hameed Salem; Mohammed Abdel-Hafez Ali; Mohammed Al-Sayed Abd-Same; Islam Ayoub Journal: Ann Med Surg (Lond) Date: 2022-06-07
Authors: Alicia M Alcamo; Mira K Trivedi; Carly Dulabon; Christopher M Horvat; Geoffrey J Bond; Joseph A Carcillo; Michael Green; Marian G Michaels; Rajesh K Aneja Journal: Am J Transplant Date: 2021-07-28 Impact factor: 8.086